Olfera Corp

Unicycive Therapeutics, Inc., based in Los Altos, CA, is dedicated to transforming kidney care through innovative healthcare solutions. Founded with a mission to identify and capitalize on overlooked opportunities, the company aims to develop life-changing medicines for patients with urgent medical needs. With a focus on kidney health, Unicycive employs an agile development process driven by a best-in-class team, allowing them to swiftly advance promising technologies into commercial therapies. As kidney disease affects more than 1 in 7 adults in the U.S., Unicycive is committed to addressing this significant unmet need with cutting-edge science and a fearless approach to innovation. Generated from the website

Alexza Pharmaceuticals is a pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The company's technology, the Staccato system, vaporizes unformulated drug compound to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience. Alexza Pharmaceuticals has four product candidates in clinical development: AZ-001 (Staccato prochlorperazine) for the treatment of acute migraine headaches; AZ-002 (Staccato alprazolam) for the acute treatment of panic attacks associated with panic disorder; AZ-004 (Staccato loxapine) for the treatment of acute agitation in patients with schizophrenia; and AZ-003 (Staccato fentanyl) for the treatment of patients with acute pain. Alexza Pharmaceuticals is located in Palo Alto, Calif.

Ascendis Pharma Inc., headquartered in Palo Alto, California, is a biopharmaceutical company focused on developing innovative therapies through its proprietary TransCon technology. The company's pipeline includes treatments in endocrinology and oncology aimed at improving patient outcomes worldwide. With operations across both Europe and the United States, Ascendis Pharma is committed to advancing medical science and enhancing the lives of patients through its ongoing clinical trials and product development initiatives. The firm's dedication to corporate responsibility and patient-centered care underscores its mission to make a meaningful impact in the healthcare landscape. Generated from the website